They demonstrated sensitivities of 95% (anti-Dsg1, PF), 100% (anti-Dsg3, PV), 95% (anti-BP180, BP), 60% (anti-BP230, BP), 93% (anti-type VII collagen, EBA), and 86% (anti-envoplakin, paraneoplastic pemphigus), and specificities in the range of 97–100% (114). This evidence concerns the gene DSG3 and paraneoplastic pemphigus.